Differentiation of hematopoietic progenitor cells into T lymphocytes generally occurs in the unique environment of the thymus, a feature that has hindered efforts to model this process in the laboratory. We now report that thymic stromal cultures from rhesus macaques can support T-cell differentiation of human or rhesus CD34+ progenitor cells. Culture of rhesus or human CD34+ bone marrow-derived cells depleted of CD3' lymphocytes on rhesus thymic stromal monolayers yielded CD3+CD4+CD8+, CD3+CD4+CD8-, and CD3+CD4-CD8+ cells after 10 to 14 days. In addition t o classical T lymphocytes, a discrete population of CD3+CD8'OCD16+CD56+ cells was detected after 14 days in cultures inoculated with rhesus CD34' cells. CD3+ T cells arising from these cultures were not derived from contaminating T cells present in the CD34+ cells used to inoculate thymic stromal monolayers or from the thymic monolayers, as shown by labeling of cells with the lipophilic membrane OST T CELLS ARISE in the thymus, where primitive
Differentiation of hematopoietic progenitor cells into T lymphocytes generally occurs in the unique environment of the thymus, a feature that has hindered efforts to model this process in the laboratory. We now report that thymic stromal cultures from rhesus macaques can support T-cell differentiation of human or rhesus CD34+ progenitor cells. Culture of rhesus or human CD34+ bone marrow-derived cells depleted of CD3' lymphocytes on rhesus thymic stromal monolayers yielded CD3+CD4+CD8+, CD3+CD4+CD8-, and CD3+CD4-CD8+ cells after 10 to 14 days. In addition t o classical T lymphocytes, a discrete population of CD3+CD8'OCD16+CD56+ cells was detected after 14 days in cultures inoculated with rhesus CD34' cells. CD3+ T cells arising from these cultures were not derived from contaminating T cells present in the CD34+ cells used to inoculate thymic stromal monolayers or from the thymic monolayers, as shown by labeling of cells with the lipophilic membrane OST T CELLS ARISE in the thymus, where primitive M hematopoietic cells pass through a complex series of developmental stages ultimately resulting in mature CD4+ and CD8+ T cells.',' The process of thymic T-cell differentiation is marked by a number of distinctive events, including rearrangements of germline T-cell receptor genes and obligatory interactions of developing T cells with major histocompatibility molecules resulting in the deletion of autoreactive cells and the positive selection of cells able to recognize self-major histocompatibility complex (MHC) molecules. A number of different cells in the thymus play critical roles in the process of supporting T-cell differentiation, including MHC class 11-positive thymic epithelial cells and mesenchymal cell^,^,^ and, in general, T-cell differentiation is thought to be dependent on the complex three-dimensional structure of an intact thymic environment. ' Experimental study of human T lymphopoiesis has been largely limited to the SCID-hu mouse in vivo model: murine dye PKH26. Expression of the recombinase activation gene RAG-2, which is selectively expressed in developing lymphocytes, was detectable in thymic cultures inoculated with CD34+ cells but not in CD34' cells before thymic culture or in thymic stromal monolayers alone. Reverse transcriptasepolymerase chain reaction analysis of T cells derived from thymic stromal cultures of rhesus and human CD34+ cells showed a polyclonal T-cell receptor repertoire. T-cell progeny derived from rhesus CD34+ cells cultured on thymic stroma supported vigorous simian immunodeficiency virus replication in the absence of exogenous mitogenic stimuli. Rhesus thymic stromal cultures provide a convenient means to analyze T-cell differentiation in vitro and may be useful as a model of hematopoietic stem cell therapy for diseases of T cells, including acquired immunodeficiency syndrome. 0 1996 by The American Society of Hematology.
and human thymic organ culture^,^^' and human thymic monolayers."' However, these existing techniques all share some shortcomings, among them the potential for perturbations in T-cell development due to the significant phylogenetic differences between mice and humans, difficulty in obtaining a consistent source of tissue, and the limited number of cells available for functional studies. We hypothesized that thymic stromal cultures derived from rhesus macaques would provide the appropriate conditions for T-lymphocyte development of rhesus and human CD34+ progenitor cells.
In this study, we show that thymic stromal cultures from rhesus macaques can support T-cell differentiation of human and rhesus CD34+ bone marrow progenitor cells. T cells derived from these cultures acquire cell surface markers in a temporal pattern characteristic of normal T lymphopoiesis, express a polyclonal T-cell receptor repertoire, and are susceptible to infection with the simian immunodeficiency virus (SIV). For personal use only. on October 22, 2017. by guest www.bloodjournal.org From suspension was then washed once in culture media (RPMI 1640, 10% heat-inactivated fetal calf serum [FCS] , 10 IU/mL penicillin, 10 pg/mL streptomycin, and 1 mmol/L L-glutamine). Thymic stromal cultures were established using either fresh or cryopreserved cells cultured in 24-well plates at a concentration of 1 X lo6 cells per well in a volume of 2 mL culture medium. After 2 days in a 37°C incubator with 5% CO,, the nonadherent cells were removed by washing three times with culture media. The monolayer was then maintained in culture media that was changed at least twice per week. After 6 days in culture, CD34+ cells were added to the monolayer at a concentration of 1 x I d cells per well.
MATERIALS AND METHODS

Animals
Thymic stromal cultures were established as described in 4-well chamber slides (Costar, Cambridge, MA). Once mature (6 to 10 days), the slides were washed with PBS and fixed with 2% paraformaldehyde. Slides were incubated with 2% normal horse serum in PBS for 30 minutes. Biotinylated antibodies directed against class I1 MHC (DK-22; Dako, Carpinteria, CA), class I MHC (W632; Dako), pan-cytokeratin (MOVFll6; Dako), vimentin (Vim 3B4G; Dako), desmin (D33; Dako), and CD68 (EBM-11; Dako) were used for 30 minutes at 4°C. After washing, slides were exposed to streptavidin-peroxidase and then developed with 3,3'-diaminobenzidine as a substrate. Controls included incubation with secondary antibodies (see above) or unconjugated mouse antibodies.
Purified CD34+ cells (1 X lo6) cells were transferred to a 15-mL polypropylene conical tube and washed once in medium without serum at 25°C. After centrifugation, cells were resuspended in 25 pL of serum-free medium and rapidly mixed with PKH26 (4 X IO6 pmoVL; Sigma) for 5 minutes at room temperature.
RPMI medium supplemented with 10% FCS was then added to stop the labeling reaction. Cells were washed three times and analyzed by fluorescence microscopy (546 nm excitation, Texas Red filter cube) and flow cytometry (FACScan; Becton Dickinson, Mountain View, CA) for efficiency of labeling.
Bone marrow harvest and immunomagnetic bead CD34 cell isolation. Heparinized bone marrow was harvested from the posterior iliac crest of rhesus macaques and normal human volunteers. All animal procedures were performed under protocols approved by the Harvard Medical School Animal Use Committee. Rhesus macaques were anesthetized with ketamine (10 to 20 mgkg IM) and I% xylocaine subcutaneously at the bone marrow aspirate site. Human volunteers provided written informed consent and were studied under a protocol approved by the Deaconess Hospital Institutional Review Board. Mononuclear cells were separated by centrifugation on Ficoll (Ficoll 1077; Sigma) and were cultured at 37°C overnight on polystyrene. Remaining erythrocytes were lysed using 0.15 m o m ammonium chloride. CD34+ cells were isolated using a magnetic antihuman CD34' bead that cross-reacts with rhesus CD34 (Dynal, Lake Success, NY) and separated from these beads using an anti-idiotype antibody (DETACHABEAD; Dynal) according to the manufacturer's protocol. The purity of CD34+ cells obtained using this technique ranged from 93% to 95% for rhesus and 89% to 91% for human. Purified CD34+ cells were further depleted of CD3' cells by incubation with a CD3-specific antibody (for rhesus cells, 6G12"; and for human cells, 12F6I2) followed by incubation with sheep antimouse magnetic beads (Dynal) and depletion of cells bound to beads using a magnetic separation device (Dynal).
Fluorescent antibody analysis and cell sorting. Rhesus CD34' cells were incubated with a biotinylated anti-CD34 antibody (Immunotech, Westbrook, ME), followed by phycoerythrin (PE)-streptavidin (Molecular Probes, Eugene, OR) and anti-CD38-fluorescein isothiocyanate (FITC; OKTIO; Ortho Diagnostics, Raritan, NJ), and resuspended in PBS with 2% FCS. CD34' cells were sorted on a FACS Vantage (Becton Dickinson) into CD34h' CD38-and CD34TD38' cells. Fluorescence was excited using an argon CoherImmunohistochemistry.
PKH26 labeling.
ent Enterprise laser generating 90 mW of 488 nm light. FITC emission was detected through a 530/30 nm band pass filter, and PE emission was detected through a 575/26 nm band pass filter. Fluorescence was directed to the appropriate detectors using a 560 nm short pass dichroic.
Antibodies used for immunophenotyping of rhesus cells included anti-CD3 (6G12; kindly provided by J. Wong, Massachusetts General Hospital)," anti-CD4 (OKT4; Ortho Diagnostics), anti-CD8 (Leu-2a; Becton Dickinson), anti-CD 16 (Immunotech), anti-CD56 (Becton Dickinson), anti-CD34 (QBend-10; Immunotech), and anti-TCR y6 (T Cell Diagnostics, Wobum, MA). An antibody specific for human CD3 (Leu-4; Becton Dickinson) was used for phenotyping of human cells. Cells were stained in the presence of staining media (PBS with 2% mouse serum). After antibody staining, the cells were either analyzed while viable in staining media or fixed with fresh 2% paraformaldehyde, Three-color flow cytometry analysis of the cells was performed using a FACScan (Becton Dickinson).
T cells derived from CD34+ cells were washed and resuspended in RPMI with 10% FCS at a concentration of IO6 cells/mL. One hundred microliters (10s cells) was added to each well of a 96-well plate. Cells were stimulated with either concanavalin A (ConA; 5 pg/mL) or monoclonal antibodies to CD3 (6G12) and CD28 (CD28.2; Immunotech; 0.15 pg/mL) in the presence of interleukin-2 (IL-2; 20 U/mL) and irradiated human peripheral blood mononuclear cells (PBMC; IO5 cells/well in 100 pL of RPMI with 10% FCS). Purified goat antimouse F(ab)', fragments (Kirkegard and Perry Laboratories, Gaithesberg, MD) was used as a crosslinking agent for the experimental conditions in which monoclonal antibodies to CD3 and CD28 were used. Wells were pretreated with 1.25 pg/mL of goat antimouse antibody for 45 minutes at 37°C and washed three times before the addition of monoclonal antibodies to CD3 and CD28. Controls included T cells alone, T cells plus irradiated PBMC, and T cells plus mitogenic stimuli without IL-2 or irradiated PBMC. After 7 days in culture at 37T, each well was pulsed with 1 pCi of methyL3H-Thymidine (DuPont, NEN, Boston, MA) for 16 hours and harvested onto a glass fiber filter (Tomtec, Harvester 96, Orange, CT) and the incorporation of 'H-thymidine was determined using a liquid scintillation counter (Micro Beta Plus; Wallac, Gaithersburg, MD). Twelve replicate wells were assayed for each condition.
Reverse transcriptase-polymerase chain reaction (RT-PCR) analysis of RAG-2 expression. mRNA was extracted from nonadherent cells grown on a thymic monolayer or from CD34' cells before inoculation of the thymic culture. RNA extraction was performed using guanidinium thiocyanate and oligo dT spun columns (QuickPrep Micro mRNA Purification Kit; Pharmacia Biotech Inc, Piscataway, NJ) and mRNA samples were stored at -70°C. cDNA was then prepared by reverse transcription using random primers and Moloney reverse transcriptase (GIBCO-BRL, Grand Island, NY). cDNA was amplified using primers specific for a 415-bp region of the human RAG2 gene.'' The oligonucleotide primers were synthesized on a model 394 DNA/RNA synthesizer (Applied Biosystems Inc, Foster City, CA). The sequences of the RAG2 primers were as follows: 5' primer, GTC CCG GGC GCT GCA (669-683); 3' primer, CCT CCC ACA CGC Tr'G CAG T (1082-1064); and probe, CGT TGG GTC GGT GTC AGC CAC TCT CAC CTC CC (701-733). One quarter of the cDNA product was added to each PCR reaction (final volume, 50 pL) with 1 pmoVL of each oligonucleotide primer and 2.5 U Taq DNA Polymerase (Pharmacia). PCR amplification was performed in a Gene Amp 9600 thermal cycler (Perkin Elmer Corp, Nonvalk, CT) for 35 cycles of denaturation at 95°C for 30 seconds, annealing at 65°C for 30 seconds, and extension at 72°C for 30 seconds. PCR products were separated on 1.5% agarose gels
Proliferation assays.
For personal use only. containing ethidium bromide and photographed under UV light. Specilicity was confirmed by Southern blot hybridization with a digoxigcnin-labeled 32-base prohe at 55°C for 2 hours using Expresshyb Hybridization solution (Clontcch. Palo Alto, CA), followed by incubation with an antitligoxigenin antibody alkaline phosphatase conjugate and detection by chemiluminescence (Roehringer Mannheim. Indianapolis. IN). Parallel amplifications performed using RNA samples without reverse transcription were negative. As a control for RNA extraction, amplilication of cDNA was performed using P-actin primers (Clontech).
RT-PCR cinti1~si.s of T-cdl receptor (TCR) VD chrriri repertoire. cDNA was prepared using random primers and avian myeloblastosis virus reverse transcriptase (Proniega. Madison. W1). For RT-PCR analysis of rhesus TCR V P chains. a 50 p L PCR reaction containing I .5 mniol/L Mg. 0. I nimollL of each dNTP, 2.5 U of Taq polymerase. and 600 nmollL of the antisense C P primer was aliquoted from ;I master mix into 0.2 mL Microamp tubes (Perkin Elmer. Norwalk, CT) each containing 600 nmollL of a different Vg primer or a sense C P primer.'" cDNA from each time point (5 pL) was aliquoted into each 45-pL reaction tube. Positive controls (CP and P-actin primers) and negative controls (no AMV reverse transcriptase and reagent mix without template) were run simultaneously in separate reaction tubes for each time point. PCR amplification was performed in a Gene Amp 9600 thermal cycler. Reagents were added to tubes at 4°C and then immediately transferred to the thermal cycler for amplification using 30 cycles at 94°C. 55°C. and 72°C for I minute each. PCR products were separated on a 1.5% agarose gel, stained with ethidium bromide. and photographed under UV light. RT-PCR analysis of human TCR Vg chains was performed using a similar technique. as previously descrihed in detail."
Nonadherent and adherent cells from thymic stromal cultures were infected with SIVz3,, at a multiplicity of infection of 0.01 TCID,,Jcell for 4 hours at 37°C. SIV irfectiori of rhyrnic .srromtrl cri1rrrre.s.
Free virus was removed by vigorously washing three times with PBS. Infections were initiated at day 0, 7, and 14 of thymic stromal cultures. Infections were performed in duplicate. Controls included uninfected cells and cells exposed to SIV,lo that had been heatinactivated at 56°C for 120 minutes.
Detection of SIV 1727 gn,? cmtigen. Cell-free supernatants were collected twice weekly for the duration of the thymic monolayer culture and stored at -80°C. Collected supernatants were diluted by the addition of 1/10 volume of 5% Triton-X 100 (Coulter. Hialeah. FL) and stored at -20°C until assayed using a standard Coulter enzyme-linked immunosorbent assay (ELISA) kit for the detection of SIV p27 antigen, according to the manufacture's protocol.
RESULTS
Itntnunohi.stochemistn of thymic stromn. Thymic stromal cultures were established from tissue obtained from fetal rhesus macaques (range, 120 to 160 days gestational age). Both fresh and cryopreserved samples yielded similar results, and cryopreserved samples were used for the studies described herein. After 7 days of culture, immunohistochemical studies of thymic stromal cultures showed a heterogeneous mixture of cells (data not shown). A majority of cells expressed desmin and vimentin, indicative of fibroblasts. Discrete areas of thymic epithelial cells (based on staining for cytokeratin) and macrophages (based on staining for CD68) were identified. Staining for class I1 MHC was identitied predominantly in areas in which thymic epithelial cells were found, whereas class I MHC expression was more uniformly distributed throughout the thymic stromal culture.
In vitro differentintion qf T l~~m p / i o c~t e s from rhesus CD34' cel/s. T cells are derived from primitive progenitor + cells expressing CD34, but lacking expression of the T-cell marker CD3,J.6.."),"' We therefore inoculated rhesus thymic stromal cultures with purified CD34+ cells depleted of T cells (< 1 u/o residual CD3+ cells) and sequentially analyzed cells arising from these cultures for expression of CD34' and T-cell markers (Fig 1) . After 7 days of culture, CD34' expression was largely absent, and nonadherent cells displayed markers characteristic of early T-cell progenitors,'.'" including CD I , CD7, and CD45RA (data not shown). No cells expressing surface CD3 were detectable at this time. After 14 days of culture, the cell population consisted predorniiiantly of immature CD3' T cells expressing both CD4 and CD8, with a small percentage of phenotypically mature T cells expressing either CD4' or CD8 alone. During the first 14 days, we generally observed a twofold to IS-fold expansion in the number of nonadherent cells. Analysis at 21 days showed a decrease in the percentage OF immature CD4+CD8 ' cells, accompanied by an increase in mature CD3+ T cells. This sequential pattern of cell surfacc marker expression is highly consistent with inodels of' T-cell differentiation based on phenotypic studies carried out in fetal thy mu^.^^^"^"
In vitro dilrerentiation of T 1ymphoc.yte.s froni humun C11.14' cells. We also examined the ability of the rhesus thymic rtromal cultures to support T-cell differentiation of human CD34' cells. Human CD34+ cells depleted of T cells were cultured on rhesus thymic monolayer cultures. After 14 to 21 days, we observed predominately immaturc CD4 ' CDX' T cclls with a smaller number of mature CD4' and CD8' cells (Fig I) . Because the human CD3-specific monoclonal antibody used for phenotyping does not rccognizc rhesus T cells," these T cells did not originate lrom thc rhesus thymic stromal monolayer. When compared with the differentiation of rhesus CD34 ' cells, cultures of human CD34' cells on thymic stroma o n day 14 contained an increased percentage of CI14' T cells (mean, 35% v 14%; P < .0001 by Student's t-test), a decreased percentage of CD8' T cells (3% LJ 15%; /' < .0002), and a comparable percentage of CD4 "318 ' T cells (60% v 65%; not significant).
A minor population o f C1>8""" cells was observed in cells Ilia1 developed I'rom human C1134 ' cells (Fig 1 H) . These CD8""" cells showed a lower level o l CD3 surface expression when compared with ClX1"'"'' cells. A similar population of cells has been observed in human iieonatal thymus.'" CD3 ' lyrnphocytcs urc derived from CD34+ cei1.s. To confirm that T cells arising in these cultures originated as a result of in vitro T-cell differentiation of CD34+ cells, we performed ii variety of experiments to show that T-cell progeny did not reflect either contaminating T cells present in CD34 cells or T cells arising from the thymic stromal culture. Inoculation of rhesus thymic stromal cultures with highly purified rhesus C1134' prepared by fluoresccnt-activnted cell sorting (FACS; >98% CD34' cells) yielded rcsults similar to those obtained using CD34' cells purified using immunomagnetic beads. Comparable results were obtained with FACS-purified CD34 ' cells not expressing CI138, a marker expressed on Ii neage-committed hematopoietic Purificd CD34' cells grown in the presence of other adherent cells, such as bone marrow stroma and primary rhesus fibroblasts, failed to generate any T cells.
Evidence that T lyinphocytcs arising in these cultures are not derived from the thymic monolayer includes the observation that CD3 lymphocytes did not develop in thymic stromal cultures inoculated with bone marrow depleted of CD34' cells or in cultures not receiving any CD34' bone marrow cells. To provide additional data that lymphocytes arising in this thymic stromal culture system were derived from exogenous progenitor cells. we also examined the differentiation of rhesus CD34' bone marrow cells labeled with PKH26. PKH26 is a lipophilic fluorescent molecule that is stably incorporated into cell membranes and allows tracking of labeled cells in vitro." Culture of PKH26-labeled CD34' cells on thymic stromal monolayers showed the emergence of CD4'CD8' T cells and CD4' and CD8' T lymphocytes colabeled with PKH26, indicating that these T cells were derived from the CD34' cell population and not the monolayer (Fig 2) . The decrease in intensity of PKH26 staining over the 28-day culture period is consistent with dilution of membrane label after multiple rounds of cell division. Taken together, these results show that the development of T cells in thymic stromal cultures displayed an absolute dependence for both CD34' progenitors and thymic stromal tissue.
A characteristic feature of T-cell differentiation is the production of a heterogeneous population of cells exhibiting a diverse population of T-cell receptors. Generation of mature T-cell receptors is dependent on the activity of recombinase-activating genes, which are selectively expressed in developing lymphocytes and not in mature cells.*' We analyzed expression of the RAG-2 gene in thymic stromal cultures of CD34' cells at sequential time points. At day 0, no RAG-2 could be detected by RT-PCR in the initial population of rhesus CD34' bone marrow cells (Fig 3B) . RAG-?, RNA was evident in cells from thymic Temporal expression of lymphoid lineage genes.
cultures on days 7 and 14, providing additional evidence that T cells arising in these cultures result from in vitro T lymphopoiesis. RT-PCR analysis of thymic stroma not inoculated with CD34' cells yielded no RAG-2 cDNA.
To assess the diversity of T-cell receptors in mature T cells arising from thymic cultures, we examined expression of TCR V p chain transcripts by RT-PCR using a panel of PCR primers specific for individual rhesus TCR V p chains.
T cells derived from these cultures exhibited significant Tcell receptor diversity, with 22 of 25 V/3 subsets detected in T cells on day 14 of culture ( Fig 3C) . Similar levels of diversity were observed in two independent experiments, with 20 and 21 different TCR Vp chain transcripts observed.
No TCR Vg chain transcripts were detected in the CD34' cells used to inoculate these cultures (data not shown).
A comparable degree of TCR heterogeneity was observed in human T cells derived from CD34' cells cultured in the 
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A CD3 and CD28 (Fig 4) . T cells stimulated with CD3 and CD28 in the absence of irradiated PBMC did not proliferate, an observation that may reflect the fact that these T-cell lines had been maintained in culture for several weeks. In addition, both rhesus and human T cells derived from CD34' cells could be stimulated in bulk cultures with ConA in the presence of irradiated PBMC and IL-2, typically resulting in a threefold to IO-fold expansion over a IO-day period (data not shown). Expanded cells analyzed 7 to 14 days after stimulation retained the phenotype of mature T cells, with greater than 90% being CD3' and the majority of these T cells representing either CD3'CD4'CD8-or CD3'Cm-CD8' cells. These T-cell lines could be maintained in culture with repeated stimulation for up to 16 weeks. Characterization of CD16' cells derived from thymic stromal cultures. In light of evidence that natural killer cells are present in human'.'.'4 and mouse thymus," we examined the expression of the natural killer cell markers CD16 and CD56 in rhesus cells derived from thymic stromal cultures. FACS analysis on day 14 of culture showed a subpopulation of cells that coexpress CD16 and CD3 (Fig 5) . The surface level of CD3 in the CD16' population varied from low to intermediate. Three-color analysis further determined that these CD3TD16' cells also express CD56. CD8 was also detected on CD3'CD16' cells, although expression of CD8 was lower than CD8 expression on all CD3' cells. Approximately 20% to 30% of the CD3TD16' cells also expressed a yS TCR (data not shown).
SIV infection of CD3' cells derived from rhesus CD34' cells in vitro. Rhesus thymic stromal cultures were exposed to SIV,,, at an multiplicity of infection of 0.01 TCID5,,/cell at days 0, 7, and 14. No SIV replication was observed in cultures of the initiating CD34' cells alone or in thymic stromal cultures not inoculated with CD34' cells. In contrast, cultures of differentiating rhesus T cells infected on days 7 and 14 of culture were shown to be highly permissive to from thymic monolayer, because the human CD3 antibody used for phenotyping does not cross-react with rhesus CD3. Finally, in vitro T-cell differentiation supported by rhesus thymic culture was absolutely dependent on the presence of thymic stroma. CD34' cells cultured on bone marrow stroma or primary rhesus fibroblasts failed to generate any CD3' cells. Moreover, thymopoiesis occurring in rhesus thymic cultures resulted in a temporal expression of T-cell markers characteristic of normal thymic T-cell development. Inoculation of CD34' cells on thymic monolayers resulted in a loss of CD34 expression and acquisition of CDI, CD7, and CD45RA at 3 to 7 days of culture. Subsequently. CD3TD4'CDS' cells appear and make up the majority of cells at 7 to I O days of culture. with mature CD3' cells expressing either CD4 or CD8, increasing at 14 to 21 days of culture. Finally. expression of RAG-2 on day 7 but not day 0 of thymic stromal culture adds further evidence to the conclusion that T-cell progeny derived from thymic stromal cultures reflect in vitro T-cell differentiation.
T cells derived from these cultures appear to be functionally and phenotypically normal. Both rhesus and human T cells derived from thymic stromal cultures displayed multiple characteristics of mature T lymphocytes. The predominant phenotype of these cells after 14 to 28 days of culture was that of mature T cells (CD3TD4'CDS-or CD3'CD4-CD8'). RT-PCR analysis of TCR Vg chain expression documents a polyclonal T-cell population. T cells derived from thymic stromal cultures also responded to normal mitogenic stimuli using either ConA or CD3 and CD28 cross-linking in the presence of irradiated feeder cells. Repeated rounds of stimulation resulted in continued expansion of T-cell progeny. Finally, thymic cocultures were shown to be highly permissive to infection with SIV. The expansion of a polyclonal population of T cells that respond to well-defined proliferative signals, as well as the susceptibility to retroviral For personal use only. on October 22, 2017. by guest www.bloodjournal.org From infection, provides clear evidence that the cells derived from these cultures display characteristics similar to mature T cells obtained in vivo.
A subpopulation of CD3+ cells arising in thymic stromal cultures inoculated with rhesus CD34+ cells was found to express CD16, CD56, and low levels of CD8. Although expression of CD16 and CD56 is characteristic of CD3-natural killer CD3+CD16+ cells have been previously described, either in normal individilalsZ7 or in patients with lymphoproliferative disease.28 A subpopulation of these CD3+CD16+ cells express CD8,2'*'* and both TCR ap+ and TCR yS' phenotypes have been reported.z8
Rhesus thymic stromal cultures offer several advantages over existing techniques for the study of T lymphopoiesis, including the relatively close phylogenetic relationship between rhesus macaques and humans and the ability to obtain large amounts of tissue under controlled circumstances. The generation of relatively large numbers of T cells and the reproducible nature of the model should facilitate developmental and functional studies. T cells arising in thymic stromal cultures also support retroviral replication, thereby providing a model to study lentiviral pathogenesis in developing T cells.
Our results suggest that thymocytes do not display an absolute requirement for a organized three-dimensional structure in which to undergo differentiation. Furthermore, the classic developmental migration from thymic cortex to medulla may not be critical to T-cell development, because the rhesus thymic stromal cultures have no defined cortex or medulla. Although human fetal thymic stromal cultures support in vitro T-cell differentiation," murine thymic stromal monolayers are not successful in supporting the differentiation of T progenitors? The reasons for this discrepancy are not clear but may relate to species differences or culture conditions used.
Thymic stromal cultmes also offer an in vitro assay for T lymphopoiesis that compliments the routine assays currently performed to analyze stem cell function. This culture should facilitate the in vitro evaluation of stem cell therapy for both acquired and congenital disorders of T cells. In particular, this system should expedite evaluation of different vectors and expression systems directed towards stem cell therapy for H N infection.
